Cargando…

An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis

BACKGROUND: The most common infection in children with the hepatic disease with or without cirrhotic ascites is spontaneous bacterial peritonitis (SBP), which occurs in the absence of an evident intra-abdominal source of infection. The present study aims to assess the value of calprotectin in asciti...

Descripción completa

Detalles Bibliográficos
Autores principales: Honar, Naser, Nezamabadipour, Najmeh, Dehghani, Seyed Mohsen, Haghighat, Mahmood, Imanieh, Mohammad Hadi, Ataollahi, Maryam, Shakibazad, Nader, Javaherizadeh, Hazhir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245209/
https://www.ncbi.nlm.nih.gov/pubmed/35773636
http://dx.doi.org/10.1186/s12887-022-03433-9
_version_ 1784738698006364160
author Honar, Naser
Nezamabadipour, Najmeh
Dehghani, Seyed Mohsen
Haghighat, Mahmood
Imanieh, Mohammad Hadi
Ataollahi, Maryam
Shakibazad, Nader
Javaherizadeh, Hazhir
author_facet Honar, Naser
Nezamabadipour, Najmeh
Dehghani, Seyed Mohsen
Haghighat, Mahmood
Imanieh, Mohammad Hadi
Ataollahi, Maryam
Shakibazad, Nader
Javaherizadeh, Hazhir
author_sort Honar, Naser
collection PubMed
description BACKGROUND: The most common infection in children with the hepatic disease with or without cirrhotic ascites is spontaneous bacterial peritonitis (SBP), which occurs in the absence of an evident intra-abdominal source of infection. The present study aims to assess the value of calprotectin in ascitic fluid in the diagnosis of ascitic fluid infection in children with liver cirrhosis. MATERIALS AND METHODS: In this cross-section study, 80 children with underlying liver disease who attended the Hepatology and Emergency Department in Shiraz University Hospitals were studied. All the patients were evaluated by a thorough history, clinical examination, laboratory investigations, diagnostic paracentesis with PMNLs count, and Calprotectin, which was measured in 1 mL ascitic fluid by ELISA. RESULTS: Thirty-five patients (43.75%) were diagnosed with ascitic fluid infection. Of these children 6 cases had positive ascitic fluid culture (SBP). Calprotectin was high in AFI patients with a statistically significant difference in AFI patients compared to non-AFI patients. The cut-off levels were 91.55 mg /L and the area under the curve was 0.971. So it can serve as a sensitive and specific diagnostic test for detection of AFI in children with underlying liver disease. CONCLUSION: Elevated ascitic calprotectin levels in cirrhotic patients are a diagnostic and reliable marker for the detection of AFI and are considered a surrogate marker for PMN.
format Online
Article
Text
id pubmed-9245209
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92452092022-07-01 An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis Honar, Naser Nezamabadipour, Najmeh Dehghani, Seyed Mohsen Haghighat, Mahmood Imanieh, Mohammad Hadi Ataollahi, Maryam Shakibazad, Nader Javaherizadeh, Hazhir BMC Pediatr Research BACKGROUND: The most common infection in children with the hepatic disease with or without cirrhotic ascites is spontaneous bacterial peritonitis (SBP), which occurs in the absence of an evident intra-abdominal source of infection. The present study aims to assess the value of calprotectin in ascitic fluid in the diagnosis of ascitic fluid infection in children with liver cirrhosis. MATERIALS AND METHODS: In this cross-section study, 80 children with underlying liver disease who attended the Hepatology and Emergency Department in Shiraz University Hospitals were studied. All the patients were evaluated by a thorough history, clinical examination, laboratory investigations, diagnostic paracentesis with PMNLs count, and Calprotectin, which was measured in 1 mL ascitic fluid by ELISA. RESULTS: Thirty-five patients (43.75%) were diagnosed with ascitic fluid infection. Of these children 6 cases had positive ascitic fluid culture (SBP). Calprotectin was high in AFI patients with a statistically significant difference in AFI patients compared to non-AFI patients. The cut-off levels were 91.55 mg /L and the area under the curve was 0.971. So it can serve as a sensitive and specific diagnostic test for detection of AFI in children with underlying liver disease. CONCLUSION: Elevated ascitic calprotectin levels in cirrhotic patients are a diagnostic and reliable marker for the detection of AFI and are considered a surrogate marker for PMN. BioMed Central 2022-06-30 /pmc/articles/PMC9245209/ /pubmed/35773636 http://dx.doi.org/10.1186/s12887-022-03433-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Honar, Naser
Nezamabadipour, Najmeh
Dehghani, Seyed Mohsen
Haghighat, Mahmood
Imanieh, Mohammad Hadi
Ataollahi, Maryam
Shakibazad, Nader
Javaherizadeh, Hazhir
An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
title An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
title_full An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
title_fullStr An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
title_full_unstemmed An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
title_short An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
title_sort evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245209/
https://www.ncbi.nlm.nih.gov/pubmed/35773636
http://dx.doi.org/10.1186/s12887-022-03433-9
work_keys_str_mv AT honarnaser anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT nezamabadipournajmeh anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT dehghaniseyedmohsen anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT haghighatmahmood anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT imaniehmohammadhadi anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT ataollahimaryam anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT shakibazadnader anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT javaherizadehhazhir anevaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT honarnaser evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT nezamabadipournajmeh evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT dehghaniseyedmohsen evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT haghighatmahmood evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT imaniehmohammadhadi evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT ataollahimaryam evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT shakibazadnader evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis
AT javaherizadehhazhir evaluationofasciticcalprotectinfordiagnosisofasciticfluidinfectioninchildrenwithcirrhosis